Ftse Mib
34.815,91
0,46%
DAX
18.742,22
-0,08%
S&P 500
5.221,42
-0,02%
NASDAQ
16.388,24
0,29%
Bitcoin
62.973,15
0,11%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Coya Therapeutics Inc (COYA) Coya Therapeutics Inc (COYA) Notizie

Coya Therapeutics Inc

COYA
8,08
-0,13 (-1,58%)
13 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:20EDGAR2Form 8-K - Current report
09/5/202422:10BWCoya Therapeutics Provides a Corporate Update and Reports..
08/5/202423:21EDGAR2Form 8-K - Current report
26/4/202414:15BWCoya Therapeutics Presents Updated ALS Biomarker Data at the..
22/4/202414:15BWCoya Therapeutics to Participate in the Mizuho Neuroscience..
18/4/202414:15BWCoya Therapeutics to Participate in the 3rd Annual ALS Drug..
08/4/202414:15BWCoya Therapeutics Scientific Advisory Board Chairman Dr...
19/3/202413:15BWCoya Therapeutics Provides a Corporate Update and Reports..
12/3/202414:00BWCoya Therapeutics to Participate in BTIG Fireside Discussion
12/3/202413:00BWCoya Therapeutics Presents ALS Biomarker Data at Society of..
06/3/202414:15BWCoya Therapeutics Presents Biomarker Data on..
06/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:15BWCoya Therapeutics to Present Data on Immune System and..
22/2/202414:15BWCoya Therapeutics to Present Novel Biomarker Survival Data..
21/2/202414:15BWCoya Therapeutics Issues Letter to Stockholders Highlighting..
13/2/202414:15BWCoya Therapeutics Licenses Intellectual Property Rights for..
03/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202414:15BWCoya Therapeutics SAB Chairman Dr. Stanley Appel, M.D...
20/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202414:15EDGAR2Form 8-K - Current report
18/1/202414:15BWCoya Therapeutics to Participate in Upcoming Chardan Biotech..
16/1/202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/1/202414:15BWCoya Therapeutics Announces Pipeline Expansion of COYA 302..
16/1/202410:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/1/202409:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
05/1/202414:00BWCoya Therapeutics Announces Successful Pre-IND and Type C..
04/1/202422:46EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202315:46EDGAR2Form D - Notice of Exempt Offering of Securities
20/12/202314:35EDGAR2Form 8-K - Current report
20/12/202314:30BWMr. Wilbur L. Ross, Former United States Secretary of..
13/12/202314:00BWCoya Therapeutics’ CEO Dr. Howard Berman’s Letter to..
12/12/202314:00BWCoya Therapeutics Announces Closing of $26.5 Million Private..
06/12/202313:30EDGAR2Form 8-K - Current report
06/12/202313:05BWCoya Therapeutics Announces $26.5 Million Private Placement
06/12/202313:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
08/11/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:03EDGAR2Form 8-K - Current report
08/11/202315:00BWCoya Therapeutics, Inc. Provides Business Update and Reports..
27/10/202315:00BWCoya Announces Acceptance of Oral Presentation, “Regulatory..
09/10/202314:00BWCoya Therapeutics (Coya) Announces Completion of Enrollment..
05/10/202315:00BWCoya Therapeutics Presents New Experimental Data Supporting..
03/10/202315:00BWCoya Therapeutics Announces the Presentation of Human..
27/9/202315:00BWCoya Therapeutics to Present at the LD Micro Investor..
22/9/202315:00BWCoya Therapeutics Licenses Exclusive Worldwide rights to..
07/9/202315:15BWCoya Therapeutics Successfully Engineers Regulatory T Cell..
31/8/202314:00BWCoya Therapeutics Announces Publication of Potential Novel..
Apertura: 8,37 Min: 8,01 Max: 8,65
Chiusura: 8,21

La tua Cronologia

NASDAQ
COYA
Coya Therapeutics
EU
CO
Casino Guichard Perrachon
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network